IP6K1 and neoplasm: Flow cytometry analysis revealed increased total viable CD45.2+ immune cells in tumors grown from IP6K1 KO mice (Supplementary Figure S2A), suggesting more tumor-infiltrating immune cells in the IP6K1 KO tumor microenvironment.